증권사자료Fierce Biotech08.19 07:34
26/08/19 (수) 키움 제약바이오 데일리 💊
#타이드#신테카바이오#코오롱티슈진
Fierce Biotech
Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss
Following a phase 3 knee osteoarthritis failure that its CEO acknowledged caused “great disappointment and concern,” Kolon TissueGene is laying off 37 employees at its Maryland headquarters. | Following a phase 3 knee osteoarthritis failure that its CEO acknowledged caused “great disappointment and…
KiwoomResearch ↗